Statins are the first-line therapy for atherosclerotic cardiovascular disease (ASCVD) risk reduction. Statins have also been shown to be safe and well-tolerated in properly selected patients, similar ...
Drs Vidula and Lu discuss how to monitor patients for adverse effects or oral selective estrogen receptor degraders (SERDs) and how those adverse effects are managed. Ryan Haumschild, PharmD, MS, MBA: ...
It is important to be proactive and take care to prevent and/or reduce the likelihood and impact of adverse effects associated with poly (ADP-ribose) polymerase (PARP) inhibitors. This could allow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results